More Globe Newswire

View Older Stories View Newer Stories

Jul 9, 2024 04:30AM Metasphere Labs Announces a Definitive Agreement with Ecoblox and PureSky to Develop Carbon-Aware Routing Protocol
Jul 9, 2024 04:15AM RESULT OF RIKSBANK CERTIFICATE SALE
Jul 9, 2024 04:00AM COUNSLR EXPANDS INTO IOWA, PARTNERING WITH CRESTWOOD HIGH SCHOOL TO INCREASE ACCESS TO MENTAL HEALTH SUPPORT SERVICES
Jul 9, 2024 04:00AM Microbiotica to Present Positive Update on Manufacturing Progress of its Live Biotherapeutic Products for Forthcoming Melanoma and Ulcerative Colitis Clinical Studies
Jul 9, 2024 04:00AM Christie’s International Real Estate 2024 Global Luxury Mid-Year Outlook Offers Insights and Predictions for Luxury Real Estate
Jul 9, 2024 04:00AM Construction contract (Rail Baltica railway line Hagudi-Alu section)
Jul 9, 2024 04:00AM Shiprock Capital announces new Investor Relations and Business Manager
Jul 9, 2024 03:57AM Form 8.5 (EPT/RI) - musicMagpie Plc
Jul 9, 2024 03:57AM Notification of major shareholding
Jul 9, 2024 03:55AM Form 8.5 (EPT/RI) - NewRiver REIT Plc
Jul 9, 2024 03:52AM Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
Jul 9, 2024 03:50AM Form 8.5 (EPT/RI) - Global Ports Holding Plc
Jul 9, 2024 03:48AM Form 8.5 (EPT/RI) - Touchstone Exploration Inc
Jul 9, 2024 03:30AM CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
Jul 9, 2024 03:17AM NORBIT ASA - New share capital registered
Jul 9, 2024 03:16AM Share buybacks in Spar Nord Bank – transactions in week 27
Jul 9, 2024 03:05AM CRN Honors Sam Barron of CallTower as a 2024 Inclusive Channel Leader
Jul 9, 2024 03:05AM Zefiro Methane Corp. Announces Presale of Methane Emission Offset Credits to EDF Trading
Jul 9, 2024 03:05AM Advantest Achieves ASPICE Level 2 Certification for V93000 SmarTest 8 Software
Jul 9, 2024 03:01AM Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
Jul 9, 2024 03:00AM Treatment.com AI Provides Latest Corporate Update
Jul 9, 2024 03:00AM Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest
Jul 9, 2024 02:31AM Kazakh philanthropist and entrepreneur Aselle Tasmagambetova, Honored by the UN Global Compact in Central Asia
Jul 9, 2024 02:11AM Lleida.net renews its contract with Peru's Financiera Confianza for three years
Jul 9, 2024 02:02AM Stellantis Extends Benchmark Hybrid Powertrain to More Nameplates to Satisfy European Customer Demand
Jul 9, 2024 02:00AM IPC now supports hybrid network connections to Google Cloud
Jul 9, 2024 02:00AM Bedford Metals Completes Sheppard Lake Uranium Project Option Agreement
Jul 9, 2024 02:00AM Progress on share buyback programme
Jul 9, 2024 02:00AM Equinor ASA: Share buy-back
Jul 9, 2024 02:00AM IPC now supports hybrid network connections to Google Cloud
Jul 9, 2024 02:00AM Transaction in Own Shares
Jul 9, 2024 02:00AM SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
Jul 9, 2024 02:00AM KBC Group: Update regarding the KBC Group share buyback programme
Jul 9, 2024 01:54AM TextMagic group’s sales results for Q2 2024
Jul 9, 2024 01:30AM BGHL (GBP): NAV(s)
Jul 9, 2024 01:30AM BGHL (EUR): NAV(s)
Jul 9, 2024 01:30AM Sampo plc’s share buybacks 8 July 2024
Jul 9, 2024 01:00AM Amundi and Victory Capital sign a definitive agreement to become strategic partners
Jul 9, 2024 01:00AM Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease
Jul 9, 2024 01:00AM Start of Day Message
Jul 9, 2024 01:00AM Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes
Jul 9, 2024 01:00AM Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease
Jul 9, 2024 01:00AM AS Tallinna Sadam operational volumes for 2024 Q2 and 6 months
Jul 9, 2024 12:59AM Dassault Systèmes Provides Preliminary Second Quarter 2024 Results and Full Year Outlook
Jul 8, 2024 09:01PM Grupo Aeroportuario del Pacífico Announces Payment Date for the First Installment of the Capital Stock Reduction Approved at the Extraordinary Shareholders’ Meeting
Jul 8, 2024 08:37PM Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Diseas
Jul 8, 2024 08:37PM Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Di
Jul 8, 2024 08:00PM California Water Service Applauds California Supreme Court Decision Preserving Water Utilities’ Rights to Implement Rate-Making Mechanism that Supports Conservation, Protects Customers
Jul 8, 2024 08:00PM Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear rece
Jul 8, 2024 07:34PM Open Letter: Justice for Migrant Workers Demand the Provincial Government Implement Immediate Emergency Protection for Agricultural Workers
View Newer Stories View Older Stories